Investigating Stress-Induced Dopamine Release: a fMRI-PET Study
NCT ID: NCT05825677
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2023-04-11
2024-10-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Non-invasive brain stimulation applied over the dorsolateral prefrontal cortex modulates the subcortical dopaminergic transmission at rest and can reduce the hormonal and cognitive alterations induced by stress. This study aims to investigate the Non-invasive brain stimulation -induced modulation of dopamine transmission in an acute stress situation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
NCT04735172
The Impact of Reward-induced Dopamine Release on Functional Connectivity: a Combined PET/fMRI Study
NCT02801643
Relationship Between Serotonin and Brain Response to Social Dominance and Emotion Perception.
NCT03041870
Dopaminergic Disruption Induced by Traumatic Coma: Dopaminergic Pathways Abnormalities and Biomarkers of Recovery Using MRI and 18F-LBT-999 PET
NCT06930261
The Effect of Transcranial Magnetic Stimulation on Learning With Reward in Healthy Humans
NCT01260740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Method: 30 healthy subjects will be enrolled and randomized into 2 parallel groups. 15 participants will receive active Transcranial direct current stimulation , the other 15 participants will receive sham Transcranial direct current stimulation.
Transcranial direct current stimulation procedure: active Transcranial direct current stimulation corresponds to 30min of stimulation at 1mA intensity . The sham stimulation corresponds to 30s of real stimulation.
Stress paradigm: In order to induce moderate stress in humans in laboratory condition, the investigators will use the Maastricht Acute Stress test . This test is a combination between physical, hand immersion in cold water and cognitive calculation stress. The test will start 5 minutes after the beginning of stimulation session.
Stress measures: the stress response will be evaluated at the following levels:
* Neurochemical level: dopamine transmission measured with positron emission tomography
* Functional brain connectivity: resting-state networks measured with functional magnetic resonance imaging
* Hormonal level: adrenocorticotropic hormone and cortisol levels measured with blood samples
* Cognitive level: decision-making and memory assessed with delay-discounting task and reality-monitoring task, respectively
* Molecular level: expression of genes involved in the glucocorticoid receptor signaling pathway measured through blood samples Exploratory measure: Brain-Derived Neurotrophic Factor and cytoplasmic catechol-O-methyltransferase polymorphisms of participants involved in differential Transcranial direct current stimulation response will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Each subject will be assigned a randomization code, corresponding to the code to enter the tDCS device. This system allows the person who administers tDCS and the subject receiving the stimulation to be blind.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS
Active brain stimulation Direct current stimulation of DLPFC for 30min with an intensity of 1mA
tDCS actif
Active brain stimulation
Sham tDCS
Sham brain stimulation Direct current stimulation of DLPFC for 30sec with an intensity of 1mA
tDCS Sham
Sham brain stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS actif
Active brain stimulation
tDCS Sham
Sham brain stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smoker
* Non-psychotropic user
Exclusion Criteria
* Have a first-degree family history of a psychiatric disorder
* Pregnant or nursing women
* Be on medication, with the exception of oral contraceptives
* Contraindications to tDCS or MRI examination
* Participants with pacemaker or cardiac or cerebral implant
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital le Vinatier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jérôme BRUNELIN, PhD
Role: STUDY_DIRECTOR
Vinatier Hospital PsyR2 Team
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ch Le Vinatier
Lyon, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00907-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.